Acute Coronary Syndrome (ACS) | Norton Healthcare

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Acute Coronary Syndrome (ACS)

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

Sub-indication: Acute Coronary Syndrome (ACS)

Study Type: Drug Study

Principal Investigator: Vipul Panchal, M.D.
Norton Heart & Vascular Institute

Sponsor: Sponsor: CSL Behring LLC

Learn more at ClinicalTrials.gov

Email for more information: CVResearch@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Acute Coronary Syndrome (ACS) Clinical Trial

Schedule an Appointment